EDITORIAL COMMENTWhy are there delays in patients presenting with melanoma?
British Journal of DermatologyPublished 1 November 1999
V.R. Doherty
Citations3
SJR quartileQ1
SJR score2.46
SNIP2.35
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
Journal Article EDITORIAL COMMENTWhy are there delays in patients presenting with melanoma? Get access V.R. Doherty V.R. Doherty University of Edinburgh, Lauriston Building, Royal Infirmary, Lauriston Place, Edinburgh EB3 9YW V.R.Doherty Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 141, Issue 5, 1 November 1999, Pages 781–783, https://doi.org/10.1046/j.1365-2133.1999.03285.x Published: 01 November 1999
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
BMJHas mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994
215 Citations1996Graham G. Giles, Bruce K. Armstrong +3 more
Melanoma mortality in Australia peaked in about 1985 and has now plateaued, and on the basis of trends in cohorts it can be expected to fall in coming years.
BMJAudit of public education campaign to encourage earlier detection of malignant melanoma.
205 Citations1992R.M. MACKIE, David Hole
The public education campaign to encourage earlier referral and treatment of primary cutaneous malignant melanoma and thus reduce mortality related to melanoma succeeded in reducing the absolute number of thick tumours and melanoma related mortality in women.
Archives of DermatologyMelanoma and Tumor Thickness
119 Citations1999M.‐A. Richard, Jean‐Jacques Grob +18 more
Poor prognosis can be accounted for by aggressive rapidly growing tumors rather than by delays, and campaigns for early diagnosis of melanoma may no longer have a major impact on prognosis, unless they are focused on subgroups less accessible to information and medical care.
BMJReasons for poor prognosis in British patients with cutaneous malignant melanoma.
99 Citations1986V.R. Doherty, R.M. MacKie
A public education campaign was launched in the west of Scotland in June 1985 with the aim of improving recognition of early malignant melanoma and in the next six months the proportion of patients with primary melanomas categorised as "thin, good prognosis" had risen from 38% to 62%, and the proportion with tumours categorising as "thick, poor prognosis".
New England Journal of MedicineContinuing Medical Education — An Epidemiologic Evaluation
91 Citations1970Charles E. Lewis, Ruth S. Hassanein
During 1956–65, 57 per cent of the 2090 physicians practicing in Kansas participated in courses of continuing education offered by the State University.
British Journal of DermatologyAwareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment
83 Citations1999Andreas Blum, C.U. Brand +5 more
Patients detecting their lesions themselves were treated significantly later than patients in whom others had remarked on changes in a naevus, and melanomas of the head and neck were treated later than melanomas at other body sites.
The Medical Journal of AustraliaFactors related to the presentation of patients with thick primary melanomas
80 Citations1991Peter Hersey, Robert C. Burton +7 more
To identify any characteristics of patients that are associated with presentation with thick primary melanoma.
BMJMelanoma in people aged 65 and over in Scotland, 1979-89.
45 Citations1992P.M. McHenry, David Hole +1 more
Journal of Epidemiology & Community HealthEdinburgh breast education campaign on breast cancer and breast self-examination: was it worth while?
11 Citations1986M M Roberts, Susan Robinson +4 more
A health education campaign carried out at the start of a large trial of screening for breast cancer in Edinburgh showed that selected women who heard the talks were more knowledgeable about breast cancer, and a random sample of women in Edinburgh had a small but significant improvement in knowledge.